Lowered costs and incremental effectiveness could improve when using biomarker-guided selection for treatment of patients with metastatic colorectal cancer using first-line nivolumab. Choosing the ...
TAS-102 plus bevacizumab is cost-effective in China but not in the US or UK due to high incremental cost-effectiveness ratios (ICERs). The study uses a decision model to compare TAS-102 monotherapy ...
We constructed a three-state Markov model to estimate costs, quality-adjusted life-years (QALYs), incremental net monetary benefit (INMB), and incremental cost-effectiveness ratios (ICERs) in patients ...
Integrating Social Needs Screening and Resource Referral Into Standard Ambulatory Oncology Care: A Quality Improvement Project Three hundred eighty-four patients received HCT (n = 260) or standard of ...
Usual care provided 9.59 QALYs at a lifetime cost of $222,300, diet and exercise yielded 9.75 QALYs for $226,300, and semaglutide offered 10.48 QALYs at $273,500, with tirzepatide providing 10.68 ...
A detailed analysis in the Canadian Journal of Cardiology of the cost-effectiveness of semaglutide shows that with price reductions, it could meet the benchmark for healthcare value, urging ...
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today shared the results of a study ...
Please provide your email address to receive an email when new articles are posted on . SEATTLE — In eyes with center-involved diabetic macular edema, using bevacizumab first and switching to ...
Results of US CoreValve High Risk Trial Reported at TCT 2014 WASHINGTON, DC – According to a new study, transcatheter aortic valve replacement (TAVR) provided meaningful clinical benefits relative to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results